Identification and molecular characterization of Subramaniula asteroides causing human fungal keratitis: a case

Rosario Cultrera1, Riccardo Torelli2, Caterina Sarnicola3

  • 1Department of Morphology, Surgery and Experimental Medicine, Infectious Diseases Unit, University 'S. Anna' Hospital of Ferrara, Via Aldo Moro 8, 44124, Ferrara, Italy. ctr@unife.it.

BMC Infectious Diseases
|January 19, 2021
PubMed
Abstract

Insights

This study reports the first case of human keratitis caused by Subramaniula asteroides, a rare filamentous fungus. The infection was successfully treated with isavuconazole, offering a new therapeutic option for this difficult-to-diagnose condition.

Area of Science:

  • Ophthalmology
  • Mycology
  • Infectious Diseases

Background:

  • Fungal keratitis, particularly from rare genera like Subramaniula, presents diagnostic challenges and limited treatment options due to ocular barriers.
  • Traditional diagnosis relies on microscopy and cultures, which are time-consuming, delaying appropriate therapy.
  • Subramaniula asteroides is a recently identified fungus with few reported human infections, making its clinical presentation and management less understood.

Observation:

  • A 65-year-old male presented with severe keratitis unresponsive to standard antimicrobial and steroid treatment, progressing to corneal perforation.
  • Clinical examination revealed a large, pigmented corneal ulcer with hypopyon and conjunctival hyperemia, suggestive of a fungal etiology.
  • Molecular identification confirmed Subramaniula asteroides isolated from corneal scrapings.

Findings:

  • Molecular methods provided a rapid and accurate diagnosis of fungal keratitis caused by Subramaniula asteroides.
  • Antimicrobial susceptibility testing indicated sensitivity to voriconazole and isavuconazole.
  • Successful treatment of the fungal keratitis was achieved using systemic isavuconazole without reported side effects.

Implications:

  • Molecular diagnostics can significantly shorten the time to diagnosis for filamentous fungal keratitis, enabling prompt treatment.
  • Systemic isavuconazole represents a potentially safer and effective alternative to voriconazole for treating fungal keratitis, minimizing systemic adverse effects.
  • This case expands the understanding of Subramaniula asteroides as a human pathogen and highlights isavuconazole as a viable therapeutic agent.